主要股东
| 股东名称 | 最终控制人 | 持股数(万股) | 占总股本比(%) | 持股变动(万股) | 股票类型 |
|---|---|---|---|---|---|
| Boston Scientific Group plc | Boston Scientific Corporation | 20370.30 | 65.00 | 不变 | 普通股 |
| CA Medtech Investment (Cayman) Limited | CPE Holdings International Limited | 2996.54 | 9.56 | 不变 | 普通股 |
| Cosmic Elite Holdings Limited | 李静 | 1839.10 | 5.87 | 不变 | 普通股 |
| Sino Fame Ventures Limited | 李静 | 1052.84 | 3.36 | 不变 | 普通股 |
| Silvio Rudolf SCHAFFNER | Silvio Rudolf SCHAFFNER | 80.71 | 0.26 | 不变 | 普通股 |
| CPE Investment Wu Limited | CPE Holdings International Limited | 61.64 | 0.20 | 不变 | 普通股 |
持股变动
| 日期 | 股东名称 | 持股变动(万股) | 变动后持股(万股) | 变动后占比(%) | 性质 |
|---|---|---|---|---|---|
| 2023-06-06 | Cosmic Elite Holdings Limited |
|
1839.10 | 5.87 | 好仓 |
| 2023-06-06 | Nexus Partners Group Limited |
|
1839.10 | 5.87 | 好仓 |
| 2023-06-06 | Vistra Trust (Singapore) Pte. Limited |
|
1839.10 | 5.87 | 好仓 |
| 2023-06-06 | 李静 |
|
2891.95 | 9.23 | 好仓 |
| 2023-06-06 | 李静 |
|
2891.95 | 9.23 | 好仓 |
| 2023-02-09 | CA Medtech Investment (Cayman) Limited |
|
2996.54 | 9.56 | 好仓 |
| 2023-02-09 | CA Medtech Investment II Limited |
|
2996.54 | 9.56 | 好仓 |
| 2023-02-09 | CA Medtech Investment III Limited |
|
2996.54 | 9.56 | 好仓 |
| 2023-02-09 | Cosmic Elite Holdings Limited |
|
2559.90 | 8.17 | 好仓 |
| 2023-02-09 | CPE Funds III Limited |
|
3058.19 | 9.76 | 好仓 |
| 2023-02-09 | CPE Global Opportunities Fund, L.P. |
|
3058.19 | 9.76 | 好仓 |
| 2023-02-09 | CPE GOF GP Limited |
|
3058.19 | 9.76 | 好仓 |
| 2023-02-09 | CPE Holdings International Limited |
|
3058.19 | 9.76 | 好仓 |
| 2023-02-09 | CPE Holdings Limited |
|
3058.19 | 9.76 | 好仓 |
| 2023-02-09 | CPEChina Fund III, L.P. |
|
3058.19 | 9.76 | 好仓 |
| 2023-02-09 | Nexus Partners Group Limited |
|
2559.90 | 8.17 | 好仓 |
| 2023-02-09 | Vistra Trust (Singapore) Pte. Limited |
|
2559.90 | 8.17 | 好仓 |
| 2023-02-09 | 李静 |
|
3782.75 | 12.07 | 好仓 |
| 2023-02-09 | Schaffner Silvio Rudolf |
|
80.71 | 0.26 | 好仓 |
| 2023-02-09 | 李静 |
|
3782.75 | 12.07 | 好仓 |
| 2023-01-26 | Boston Scientific Corporation |
|
20370.30 | 65.00 | 好仓 |
| 2023-01-26 | Cosmic Elite Holdings Limited | 不变 | 4306.26 | 13.74 | 好仓 |
| 2023-01-26 | Nexus Partners Group Limited | 不变 | 4306.26 | 13.74 | 好仓 |
| 2023-01-26 | Vistra Trust (Singapore) Pte. Limited | 不变 | 4306.26 | 13.74 | 好仓 |
| 2023-01-26 | 李静 | 不变 | 5529.11 | 17.64 | 好仓 |
| 2023-01-26 | Schaffner Silvio Rudolf | 不变 | 427.21 | 1.36 | 好仓 |
| 2023-01-26 | 李静 | 不变 | 5529.11 | 17.64 | 好仓 |
| 2023-01-19 | CA Medtech Investment (Cayman) Limited | 不变 | 15861.46 | 50.61 | 好仓 |
| 2023-01-19 | CA Medtech Investment II Limited | 不变 | 15861.46 | 50.61 | 好仓 |
| 2023-01-19 | CA Medtech Investment III Limited | 不变 | 15861.46 | 50.61 | 好仓 |
| 2023-01-19 | CPE Funds III Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2023-01-19 | CPE Global Opportunities Fund, L.P. | 不变 | 16187.76 | 51.65 | 好仓 |
| 2023-01-19 | CPE GOF GP Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2023-01-19 | CPE Holdings International Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2023-01-19 | CPE Holdings Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2023-01-19 | CPEChina Fund III, L.P. | 不变 | 16187.76 | 51.65 | 好仓 |
| 2023-01-17 | CA Medtech Investment (Cayman) Limited | 不变 | 15861.46 | 50.61 | 好仓 |
| 2023-01-17 | CA Medtech Investment II Limited | 不变 | 15861.46 | 50.61 | 好仓 |
| 2023-01-17 | CA Medtech Investment III Limited | 不变 | 15861.46 | 50.61 | 好仓 |
| 2023-01-17 | CPE Funds III Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2023-01-17 | CPE Global Opportunities Fund, L.P. | 不变 | 16187.76 | 51.65 | 好仓 |
| 2023-01-17 | CPE GOF GP Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2023-01-17 | CPE Holdings International Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2023-01-17 | CPE Holdings Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2023-01-17 | CPEChina Fund III, L.P. | 不变 | 16187.76 | 51.65 | 好仓 |
| 2022-12-10 | Boston Scientific Corporation |
|
18846.80 | 60.14 | 好仓 |
| 2022-12-10 | CA Medtech Investment (Cayman) Limited | 不变 | 15861.46 | 50.61 | 好仓 |
| 2022-12-10 | CA Medtech Investment II Limited | 不变 | 15861.46 | 50.61 | 好仓 |
| 2022-12-10 | CA Medtech Investment III Limited | 不变 | 15861.46 | 50.61 | 好仓 |
| 2022-12-10 | Cosmic Elite Holdings Limited | 不变 | 4306.26 | 13.74 | 好仓 |
| 2022-12-10 | CPE Funds III Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2022-12-10 | CPE Global Opportunities Fund, L.P. | 不变 | 16187.76 | 51.65 | 好仓 |
| 2022-12-10 | CPE GOF GP Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2022-12-10 | CPE Holdings International Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2022-12-10 | CPE Holdings Limited | 不变 | 16187.76 | 51.65 | 好仓 |
| 2022-12-10 | CPEChina Fund III, L.P. | 不变 | 16187.76 | 51.65 | 好仓 |
| 2022-12-10 | Nexus Partners Group Limited | 不变 | 4306.26 | 13.74 | 好仓 |
| 2022-12-10 | Vistra Trust (Singapore) Pte. Limited | 不变 | 4306.26 | 13.74 | 好仓 |
| 2022-12-10 | 李静 | 不变 | 5529.11 | 17.64 | 好仓 |
| 2022-12-10 | 李静 | 不变 | 5529.11 | 17.64 | 好仓 |
| 2021-09-24 | Cosmic Elite Holdings Limited |
|
4306.26 | 13.74 | 好仓 |
| 2021-09-24 | Nexus Partners Group Limited |
|
4306.26 | 13.74 | 好仓 |
| 2021-09-24 | Vistra Trust (Singapore) Pte. Limited |
|
4306.26 | 13.74 | 好仓 |
| 2021-09-24 | 李静 |
|
5529.11 | 17.64 | 好仓 |
| 2021-09-24 | 李静 |
|
5529.11 | 17.64 | 好仓 |
| 2021-09-10 | Morgan Stanley |
|
2196.60 | 7.00 | 好仓 |
| 2021-08-25 | Morgan Stanley |
|
1896.90 | 6.05 | 好仓 |